FICO Recognized by Chartis as Category Winner in Innovation, AI Applications, and Financial Crime-Enterprise Fraud; Ranked Sixth Overall in the 2021 Chartis RiskTech 100® Report

Position Reflects FICO’s Analytic Innovation Strategy and Ability to Help Organizations Manage the Complexity of Their Analytic Assets

PR Newswire

SAN JOSE, Calif., Nov. 30, 2020 /PRNewswire/ —

Highlights:

  • FICO ranked sixth in this year’s RiskTech 100® – a comprehensive study of the world’s major solution providers in risk and compliance technology
  • FICO was recognized as category winner in Innovation for the fourth consecutive year
  • FICO also won category awards for AI Applications and Financial Crime – Enterprise Fraud

Global analytics software provider FICO, today announced that it has ranked sixth in Chartis Research’s annual RiskTech100® report of world’s leading risk technology providers. FICO also won category awards for Innovation, AI Applications, and Financial Crime – Enterprise Fraud.

“FICO’s top-ten ranking reflects its innovation strategy”, said Sid Dash, research director at Chartis Research. “This involves expanding the use of analytics to new areas, converging analytic solutions where logical, and helping organizations manage the complexity of their analytic assets.”

FICO has been responsible for multiple industry-changing innovations in artificial intelligence, machine learning, and other contextually-driven analytics methods. FICO’s rich portfolio of analytics solutions helps clients grapple with ever larger volumes and variety of data in real time across the enterprise. In addition, FICO fraud solutions protect over 9000 financial institutions, telecommunication organizations, auto finance, insurance companies, and government agencies from losses and damaged customer relationships caused by fraud and related criminal behavior.

“We are extremely proud of this recognition and remain committed to leveraging our deep industry expertise and leading-edge solutions to help our clients solve their most complex business challenges,” said Nikhil Behl, chief marketing officer at FICO. “FICO is focused on driving new innovations in AI, machine learning, and analytics solutions to enable our clients to deliver unsurpassed customer experiences while mitigating risk.”

Now in its 15th year, the Chartis RiskTech100® report is a comprehensive study of the world’s major solution providers in risk and compliance technology. The rankings in the report reflect the analysts’ opinions, along with research into market trends, participants, expenditure patterns and best practices.

About FICO

FICO (NYSE: FICO) powers decisions that help people and businesses around the world prosper. Founded in 1956 and based in Silicon Valley, the company is a pioneer in the use of predictive analytics and data science to improve operational decisions. FICO holds more than 195 US and foreign patents on technologies that increase profitability, customer satisfaction and growth for businesses in financial services, telecommunications, health care, retail and many other industries. Using FICO solutions, businesses in more than 100 countries do everything from protecting 2.6 billion payment cards from fraud, to helping people get credit, to ensuring that millions of airplanes and rental cars are in the right place at the right time.

Learn more at https://www.fico.com.

Join the conversation at https://twitter.com/fico & https://www.fico.com/en/blogs/

FICO is a registered trademark of Fair Isaac Corporation in the U.S. and other countries.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/fico-recognized-by-chartis-as-category-winner-in-innovation-ai-applications-and-financial-crime-enterprise-fraud-ranked-sixth-overall-in-the-2021-chartis-risktech-100-report-301180798.html

SOURCE FICO

Ribbon Named “Company of the Year” in the 2020 Big Business Awards’ Telecommunications Category

Award program rewards the companies, products and people that are leading their respective industries

PR Newswire

WESTFORD, Mass., Nov. 30, 2020 /PRNewswire/ — Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications software and network solutions to service providers, enterprises, and critical infrastructure sectors, today announced that it has received the “Company of the Year (Telecommunications)” distinction in the Business Intelligence Group‘s 2020 BIG Awards for Business. The organization’s annual industry awards program relies on industry leaders who volunteer to read, score and judge nominations.

“This has been an extraordinary year. The Ribbon – ECI merger doubled the size of our company and significantly expanded our solutions portfolio to help address the needs of our customers during an unprecedented global pandemic and beyond,” said Patrick Joggerst, Chief Marketing Officer and Executive Vice President of Business Development, Ribbon. “I’m so proud of our team for the hard work and dedication they’ve put in during this exceptional time, and of course want to extend my congratulations to the other winners as well.”

Ribbon’s comprehensive suite of cloud, edge and IP optical solutions thread people and networks together. Found in the world’s largest communications service providers and enterprises, our flexible, secure and customizable solutions enable our customers to reap the benefits of simplified, efficient and cost-effective communications at any point in their network modernization journey.

“We are so proud to reward Ribbon for their outstanding 2020 achievements,” said Maria Jimenez, chief nomination officer of the Business Intelligence Group, “This year’s group of winners are clearly leading by example in the global business community.”

About Business Intelligence Group
The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, business executives—those with experience and knowledge—judge the programs. The organization’s proprietary and unique scoring system selectively measures performance across multiple business domains and then rewards those companies whose achievements stand above those of their peers.

About Ribbon
Ribbon Communications (Nasdaq: RBBN) delivers global communications software and packet and optical network solutions to service providers, enterprises and critical infrastructure sectors. We engage deeply with our customers, helping them modernize their networks for improved competitive positioning and business outcomes in today’s smart, always-on and data-hungry world. Our innovative, end-to-end solutions portfolio delivers unparalleled scale, performance, and agility, including core to edge IP solutions, cloud-native offers, leading-edge software security and analytics tools, as well as 5G-ready packet and optical networking solutions acquired via our recent merger with ECI Telecom. To learn more about Ribbon visit rbbn.com..

Important Information Regarding Forward-Looking Statements  
The information in this release contains forward-looking statements regarding future events that involve risks and uncertainties. All statements other than statements of historical facts contained in this release are forward-looking statements. The actual results of Ribbon Communications may differ materially from those contemplated by the forward-looking statements. For further information regarding risks and uncertainties associated with Ribbon Communications’ business, please refer to the “Risk Factors” section of Ribbon Communications’ most recent annual or quarterly report filed with the SEC. Any forward-looking statements represent Ribbon Communications’ views only as of the date on which such statement is made and should not be relied upon as representing Ribbon Communications’ views as of any subsequent date. While Ribbon Communications may elect to update forward-looking statements at some point, Ribbon Communications specifically disclaims any obligation to do so.

 


Investor Relations


APAC, CALA & EMEA Press

Monica Gould

Catherine Berthier

+1 (212) 871-3927

+1 (646) 741-1974


[email protected] 



[email protected]

 


North American Press 


Analyst Relations

Dennis Watson 

Michael Cooper

+1 (214) 695-2224 

+1 (708) 212-6922



[email protected]



[email protected]
 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ribbon-named-company-of-the-year-in-the-2020-big-business-awards-telecommunications-category-301180881.html

SOURCE Ribbon Communications Inc.

Talend Achieves AWS Migration Competency Status and AWS Outposts Ready Designation

Multiple designations demonstrate Talend’s commitment to accelerate data migration and to speed strategic business outcomes for AWS customers

PR Newswire

REDWOOD CITY, Calif., Nov. 30, 2020 /PRNewswire/ — Talend (NASDAQ: TLND), a global leader in data integration and integrity, today announced at AWS re:Invent 2020 that it has achieved the Amazon Web Services (AWS) Migration Competency and AWS Outposts Ready designations.

AWS Migration Competency
Talend achieved Amazon Web Services (AWS) Migration Competency status. This designation recognizes that Talend provides proven technology and deep expertise to help customer’s move successfully to AWS, through all phases of complex migration projects, discovery, planning, migration and operations. This is the third AWS Competency Talend has received, having previously achieved AWS Data & Analytics Competency and AWS Retail Competency designations.

Achieving the AWS Migration Competency differentiates Talend as an AWS Partner that provides specialized demonstrated technical proficiency and proven customer success with specific focus on Technology for Data Migration. To receive the designation, AWS Partners must possess deep AWS expertise and deliver solutions seamlessly on AWS. 

With Talend and AWS, customers can move mass amounts of data very quickly into an AWS service using any legacy or on-premises data source. Customers can migrate data while managing their AWS resources using Talend Data Fabric, which includes data bulk loading and ingestion, cluster management for Amazon Redshift and Amazon EMR, and enterprise control for Amazon Simple Storage Service (Amazon S3).

AWS Outposts Ready
Talend achieved the Amazon Web Services (AWS) Outposts Ready designation, part of the AWS Service Ready Program. This designation recognizes that Talend has demonstrated successful integration of Talend Data Fabric with AWS Outposts deployments. AWS Outposts is a fully managed service that extends AWS infrastructure, AWS services, APIs, and tools to virtually any datacenter, co-location space, or on-premises facility for a truly consistent hybrid experience.

Recognized for its third AWS Service Ready designation, Talend integrates with AWS Outpost, Amazon Redshift, and Amazon Aurora. With Talend and AWS, shared customers can make business-critical decisions with confidence knowing that their data in AWS, whether in the cloud or in a hybrid environment, is fully reliable and trustworthy. 

“Many companies are modernizing their application performance monitoring systems by leveraging SaaS based solutions,” said Joshua Burgin, General Manager, AWS Outposts, Amazon Web Services, Inc. “We are delighted to welcome Talend to the AWS Outposts Ready Program. Talend Data Fabric can help customers monitor, troubleshoot, and optimize application performance for workloads operating on AWS Outposts, in AWS Regions, and on customer-owned hardware for a truly consistent hybrid experience.”

Achieving the AWS Outposts Ready designation differentiates Talend as an AWS Partner with a product fully tested on AWS Outposts. AWS Outposts Ready products are generally available and supported for AWS customers, with clear deployment documentation for AWS Outposts. AWS Service Ready Partners have demonstrated success building products integrated with AWS services, helping AWS customers evaluate and use their technology productively, at scale and varying levels of complexity.

“Talend is proud to receive AWS Migration Competency and AWS Outposts Ready status, helping us to further stand out as an innovative and strategic partner for businesses,” said Rob Cornell, Head of Technology Alliances, Talend. “Our team is dedicated to helping companies achieve their technology goals by leveraging the agility, breadth of services, and pace of innovation that AWS provides.”

Talend Data Fabric is a single platform that delivers complete, clean and uncompromised data in real time. As more data is ingested and analyzed, Talend helps organizations confidently drive insights using their data to quickly make decisions that can accelerate revenue, innovate faster, and reduce cost and risk.

Talend is a Bronze sponsor at this year’s AWS re:Invent. Please visit our virtual booth or learn more about Talend on AWS by requesting a meeting with Talend here.

About Talend  
Talend (NASDAQ: TLND), a leader in data integration and data integrity, is changing the way the world makes decisions. 

Talend Data Fabric is the only platform that brings together all the data integration and governance capabilities to simplify every aspect of working with data. Talend delivers complete, clean, and uncompromised data in real-time to all. This unified approach to data has made it possible to create the Talend Trust Score™, an industry-first innovation that instantly assesses the reliability of any dataset to bring clarity and confidence to every decision. 

Over 5,000 organizations across the globe have chosen Talend to run their businesses on trusted data. Talend is recognized as a leader in its field by leading analyst firms and industry media. For more information, please visit www.talend.com and follow us on Twitter: @Talend. 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/talend-achieves-aws-migration-competency-status-and-aws-outposts-ready-designation-301180758.html

SOURCE Talend Inc.

SVB Financial Group To Acquire WestRiver Group’s Debt Investment Business

Acquisition will launch the SVB Capital Credit Platform, enabling more investment options for institutional investors and access to growth capital in the innovation economy

PR Newswire

SANTA CLARA, Calif., Nov. 30, 2020 /PRNewswire/ — SVB Financial Group today announced that it has entered into an agreement to acquire the debt fund business of WestRiver Group, a Seattle-based provider of integrated capital solutions for the global innovation economy. The acquisition will enable SVB Capital, SVB Financial Group’s funds management business, to establish the SVB Capital Credit Platform to provide institutional investors with additional investment opportunities in the innovation economy and provide new debt options to Silicon Valley Bank’s commercial banking clients. SVB Financial Group is the parent company of Silicon Valley Bank, the bank of the world’s most innovative companies and their investors.

SVB has had a long-standing relationship with Seattle-based WestRiver Group and its founder and CEO Erik Anderson. The WestRiver debt team provides debt capital to venture capital and private equity-backed technology and life science companies. Over the past eight years, WestRiver’s debt program has continuously expanded to augment and complement SVB’s growth, providing Silicon Valley Bank with capital to execute on partnered transactions. With the introduction of the SVB Capital Credit Platform, SVB Capital and Silicon Valley Bank will be able to meet the larger debt requirements of their investment and lending clients and provide new and relevant financing solutions.

SVB Capital has been investing in the innovation economy for more than 20 years and manages $5.5B in assets across multiple funds. Limited partners look to SVB Capital for access to the most promising companies and fund managers in the innovation economy. The SVB Capital Credit Platform expands the fund family to existing and new SVB Capital investors. Funds in the Credit Platform will provide a differentiated risk profile and investment duration designed for investors looking for access and returns from the innovation sector.

“WestRiver Group has been a fantastic partner to SVB for the last eight years. Together we have supported innovative companies across the country with the financing they need to scale,” said John China, President of SVB Capital. “Erik and his team are a welcome addition to SVB Capital and will be instrumental in developing our credit platform and delivering on SVB’s mission to be the best partner for technology and life science companies and their investors.

The transaction is expected to close by the end of 2020. Upon closing, Erik Anderson will join SVB as the Executive Chairman of the SVB Capital Credit Platform and will also serve as Chair of the SVB Capital Advisory Committee. Erik, along with SVB veterans Jim Ellison and Pete Scott, will lead the Credit Platform, with fundraising and operation support from SVB Capital. As the Head of the Credit Platform, Jim Ellison will oversee the investment team, which will be responsible for originating, underwriting and managing the investment portfolio. Chief Credit Officer Pete Scott will define investment strategies, develop new products and oversee allocation and reporting across the investment portfolio. In addition to its location in Menlo Park, California, SVB Capital will now have an office in downtown Seattle.

“This exciting collaboration best positions SVB Capital to provide limited partners access to and potential returns in the global innovation economy,” said Anderson. “Our team, including WRG debt managing directors Ryan Grammer, JP Michael and Craig Caukin, looks forward to this valuable partnership.”

For more information about SVB, visit www.svb.com.


About SVB Financial Group



For more than 35 years, SVB Financial Group (NASDAQ: SIVB) and its subsidiaries have helped innovative companies and their investors move bold ideas forward, fast. SVB Financial Group’s businesses, including Silicon Valley Bank, offer commercial and private banking, asset management, private wealth management, brokerage and investment services and funds management services to companies in the technology, life science and healthcare, private equity and venture capital, and premium wine industries. Headquartered in Santa Clara, California, SVB Financial Group operates in centers of innovation around the world. Learn more at svb.com.

SVB Financial Group is the holding company for all business units and groups © 2020 SVB Financial Group. All rights reserved. SVB, SVB FINANCIAL GROUP, SILICON VALLEY BANK, MAKE NEXT HAPPEN NOW and the chevron device are trademarks of SVB Financial Group, used under license. Silicon Valley Bank is a member of the FDIC and the Federal Reserve System. Silicon Valley Bank is the California bank subsidiary of SVB Financial Group. [SIVB-F]


About WestRiver Group

WestRiver Group (WRG) is a collection of investment funds providing integrated capital solutions to the global innovation economy. The Seattle-based venture debt and equity company boasts a growing portfolio of investments in technology, life sciences, energy and experiential sectors. 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/svb-financial-group-to-acquire-westriver-groups-debt-investment-business-301180779.html

SOURCE Silicon Valley Bank

Cisco Announces December 2020 Events with the Financial Community

PR Newswire

SAN JOSE, Calif., Nov. 30, 2020 /PRNewswire/ — Cisco today announced that it will participate in the following conferences with the financial community during the month of December. These sessions will be webcast.  Interested parties can view these events on Cisco’s Investor Relations website at investor.cisco.com.

Raymond James Technology Investors Conference

December 7, 2020

12:20 p.m. PT / 3:20 p.m. ET
Gee Rittenhouse, Sr. Vice President and General Manager, Security Business Group

Barclays Global Technology, Media and Telecommunications Conference

December 9, 2020

11:00 a.m. PT / 2:00 p.m. ET
Bill Gartner, Sr. Vice President and General Manager, Optical Systems and Optics Group

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide leader in technology that powers the Internet. Cisco inspires new possibilities by reimagining your applications, securing your data, transforming your infrastructure, and empowering your teams for a global and inclusive future. Discover more on The Network and follow us on Twitter.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.


Investor Relations Contact:        


Press Contact:

Marty Palka                                

Robyn Blum

Cisco                                     

Cisco

408-526-6635                      

(408) 853-9848


[email protected]              


[email protected]      

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cisco-announces-december-2020-events-with-the-financial-community-301180674.html

SOURCE Cisco Systems, Inc.

Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition

Includes updated data from CPI-818 phase 1/1b trial and pre-clinical results supporting use in autoimmune lymphoproliferative syndrome (ALPS)

BURLINGAME, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that new data on CPI-818, the Company’s ITK inhibitor, will be presented at the 62nd American Society of Hematology (ASH) Annual Meeting & Exposition, which is taking place as an all-virtual event from December 5-8, 2020. This includes a poster presentation covering updated data from the Phase 1/1b clinical trial for T cell lymphoma and an oral presentation covering pre-clinical data demonstrating its potential for the treatment of autoimmune lymphoproliferative syndrome (ALPS), a rare genetic disease.

Details of the Corvus presentations are as follows:


Abstract 95:
The ITK Inhibitor CPI-818 Blocks Activation of T Cells from Autoimmune Lymphoproliferative Syndrome (ALPS) Patients and Is Active in a Murine Model of ALPS
Presenter: V. Koneti Rao, MD, FRCPA, ALPS Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH)
Oral Session: 203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Pathogenesis and Immunotherapy
Date and Time: Saturday, December 5, 2020, 1 PM ET
   

Abstract 2068:
CPI-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, Is Well-Tolerated and Active in Patients with T-Cell Lymphoma
Presenter: Michael S. Khodadoust, MD, PhD, Division of Medical Oncology, Stanford University School of Medicine
Poster Session: 624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Poster II
Date and Time: Sunday, December 6, 2020 available virtually from 10 AM to 6:30 PM ET

About Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company. Corvus’ lead product candidates are ciforadenant (CPI-444), a small molecule inhibitor of the A2A receptor, and CPI-006, a humanized monoclonal antibody directed against CD73 that has exhibited immunomodulatory activity and activation of immune cells in preclinical studies. These product candidates are being studied in ongoing Phase 1b/2 and Phase 1/1b clinical trials in patients with a wide range of advanced solid tumors. Ciforadenant is being evaluated in a successive expansion cohort Phase 1b/2 trial examining its activity both as a single agent and in combination with an anti-PD-L1 antibody. CPI-006 is being evaluated in a multicenter Phase 1/1b clinical trial as a single agent, in combination with ciforadenant and pembrolizumab. The Company’s third cancer clinical program, CPI-818, is an investigational, oral, small molecule drug that selectively inhibited ITK in preclinical studies, is in a multicenter Phase 1/1b clinical trial in patients with several types of T-cell lymphomas. The Company is also evaluating CPI-006 as a treatment for COVID-19 patients. For more information, visit www.corvuspharma.com.

About CPI-
818

CPI-818 is a small molecule drug given orally that has been shown to selectively inhibit ITK (interleukin-2-inducible T-cell kinase). It was developed to possess dual properties: to block malignant T-cell growth and modulate immune responses. ITK, an enzyme, is expressed predominantly in T-cells and plays a role in T-cell and natural killer (NK) cell lymphomas and leukemias, as well as in normal immune function. Interference with ITK signaling can modulate immune responses to various antigens. The inhibition of specific molecular targets in T-cells may be of therapeutic benefit for patients with T-cell lymphomas and in patients with autoimmune diseases. The Company is conducting a Phase 1 dose escalation trial in patients with refractory T-cell lymphomas.

INVESTOR CONTACT:

Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
+1-650-900-4522
[email protected]

MEDIA CONTACT:

Sheryl Seapy
W2O pure
+1-949-903-4750
[email protected]



Kiniksa Announces Preliminary Data from Phase 1 Trial of KPL-404


R
eceptor occupancy and TDAR suppression
shown
through Day 29 at 3 mg/kg intravenous

– Data
to-date
support
subsequent study in patients, including
potential
intravenous or subcutaneous
monthly
administration




Final data
and safety follow-up from all cohorts
expected in 1H 2021 –

HAMILTON, Bermuda, Nov. 30, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline of assets designed to modulate immunological pathways across a spectrum of diseases, today announced preliminary data from the Phase 1 clinical trial of KPL-404 in healthy volunteers. KPL-404 is a monoclonal antibody inhibitor of the CD40-CD40 ligand (CD40L) interaction, a central control node of T-cell dependent, B-cell mediated humoral adaptive immunity.

“The preliminary data from the single-ascending-dose Phase 1 study of KPL-404 are encouraging,” said Sanj K. Patel, Chief Executive Officer and Chairman of the Board of Kiniksa. “We believe the data generated to-date suggest that KPL-404 has the potential to address a broad range of autoimmune diseases. We expect final data and safety follow-up from all cohorts of the Phase 1 study in the first half of 2021.”

The Phase 1 trial of KPL-404 is a randomized, double-blind, placebo-controlled, single-ascending-dose, first-in-human study that is divided into two parts: a single dose of KPL-404 0.03 mg/kg, 0.3 mg/kg, 1 mg/kg, 3 mg/kg or 10 mg/kg intravenously (IV) and a single dose of KPL-404 1 mg/kg or 5 mg/kg subcutaneously (SC). The primary objective is to assess the safety and tolerability of KPL-404. Secondary endpoints include pharmacokinetics, CD40 receptor occupancy (RO), the immune response to the novel test antigen keyhole limpet hemocyanin (KLH) in clinically relevant dose cohorts, and the anti-drug antibody response.

All dose escalations occurred as per protocol with no dose limiting safety findings. All 6 subjects dosed with KPL-404 3 mg/kg IV showed full receptor occupancy through Day 29, which corresponded with complete suppression of the T-cell Dependent Antibody Response (TDAR) to KLH through Day 29. Consistent dose relatedness was shown in the lower dose level cohorts, including 0.03 mg/kg, 0.3 mg/kg, 1 mg/kg IV and 1 mg/kg SC. Data collection for the higher dose level cohorts, 10 mg/kg IV and 5 mg/kg SC, is ongoing.

The data to-date support subsequent study in patients, including potential IV or SC monthly administration. Kiniksa expects final data and safety follow-up from all cohorts in the first half of 2021.

The CD40-CD40L interaction has been implicated in diseases such as rheumatoid arthritis, Sjogren’s syndrome, Graves’ disease, and systemic lupus erythematosus and in prevention of solid organ transplant graft rejection, where external proof-of-concept has been previously shown.

“KPL-404 is designed to inhibit CD40-CD40L interaction, a key T-cell co-stimulatory signal pathway critical for B-cell maturation and immunoglobulin class switching. Additionally, dysregulation of the CD40-CD40L pathway has been implicated in multiple autoimmune disease pathologies and has broad reaching implications beyond humoral immunity, with its impact on dendritic cells and macrophage activity,” said John F. Paolini, MD, PhD, Chief Medical Officer of Kiniksa. “The preliminary Phase 1 data replicate and underscore the preclinical data from this program, which showed favorable pharmacokinetic and pharmacodynamic profiles, including suppression of TDAR. The data to-date support continued clinical development, and we look forward to further analyzing the totality of the dataset.”

About KPL-404

KPL-404 is an investigational humanized monoclonal antibody that is designed to inhibit CD40-CD40L interaction, a key T-cell co-stimulatory signal critical for B-cell maturation and immunoglobulin class switching and Type 1 immune responses. Kiniksa believes disrupting the CD40-CD40L interaction is an attractive approach for multiple autoimmune disease pathologies such as rheumatoid arthritis, Sjogren’s syndrome, Graves’ disease, systemic lupus erythematosus and solid organ transplant. Kiniksa owns or controls the intellectual property related to KPL-404.

About
Kiniksa

Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s clinical-stage product candidates, rilonacept, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These pipeline assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visit www.kiniksa.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions, although not all forwardlooking statements contain these identifying words. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding: our belief that KPL-404 has the potential to address a broad range of autoimmune diseases; our belief that the data to-date from our Phase 1 clinical trial of KPL-404 in healthy volunteers support continued clinical development; expected timing of final data and safety follow-up from all cohorts of the Phase 1 trial in the first half of 2021; our beliefs about the mechanisms of action of our product candidates and potential impact of their approach, including our belief that KPL-404’s disruption of the CD40-CD40L interaction is an attractive approach for multiple autoimmune disease pathologies; and our belief that all of our product candidates offer the potential for differentiation.

These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including without limitation, the following: delays or difficulty in completing our Phase 1 clinical trial of KPL-404 in healthy volunteers; potential for changes between final data and any preliminary, interim, top-line or other data from the Phase 1 clinical trial; our potential inability to replicate in later clinical trials the positive final data from our earlier clinical trials or studies; impact of additional data from us or other companies, including the potential for our data to produce negative, inconclusive or commercially uncompetitive results; potential undesirable side effects caused by KPL-404; our reliance on third parties to manufacture our product candidates; drug substance and/or drug product shortages; our reliance on third parties to conduct research, clinical trials, and/or certain regulatory activities for our product candidates, including for KPL-404; potential complications in coordinating requirements, regulations and guidelines of regulatory authorities across jurisdictions for our clinical trials, including for the Phase 1 clinical trial; the potential impact of the COVID-19 pandemic and measures taken in response to the pandemic on our business and operations as well as the business and operations of our manufacturers, CROs upon whom we rely to conduct our clinical trials, and other third parties with whom we conduct business or otherwise engage, including the FDA and other regulatory authorities; changes in our operating plan and funding requirements; and existing or new competition.

These and other important factors discussed under the caption “Risk Factors” in our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on November 5, 2020 and our other reports subsequently filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.


Every Second


Counts!™

Kiniksa
Investor and Media Contact

Mark Ragosa
(781) 430-8289
[email protected] 



TESSCO Special Committee Reiterates Call to Prevent Mr. Barnhill from Naming a Majority of the Board

TESSCO Special Committee Reiterates Call to Prevent Mr. Barnhill from Naming a Majority of the Board

Mr. Barnhill’s Unwillingness to Consider the Special Committee’s Reasonable Settlement Proposal Confirms His True Aim is Control of TESSCO’s Board

Shareholders Should Support the Settlement Proposal by Refusing to Consent to Hand Mr. Barnhill and His Nominees Control of the Board

HUNT VALLEY, Md.–(BUSINESS WIRE)–
TESSCO Technologies Incorporated (NASDAQ: TESS), a leading value-added distributor and solutions provider for the wireless industry, today issued the following statement on behalf of the Special Committee of the Board of Directors in response to Robert B. Barnhill, Jr.’s continued unwillingness to engage in settlement discussions:

On November 23, 2020, TESSCO made its third settlement proposal to Mr. Barnhill in an attempt to reach a resolution to his ongoing consent solicitation. The proposal would result in a Board composed of Mr. Barnhill, two of his nominees, TESSCO’s Chief Executive Officer, Sandip Mukerjee, the three directors who were added to the TESSCO Board in 2020 as the result of a comprehensive director search conducted with the assistance of a leading executive search firm, and Paul Gaffney, who joined the Board in 2018. The other terms of the settlement proposal are standard and customary.

If accepted, the proposal would result in the entirety of the Board being replaced since 2018, other than Mr. Barnhill whose tenure spans nearly 40 years. The resulting Board composition would align with the preferred outcomes of independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass Lewis & Co. (“Glass Lewis”), as indicated in their respective, recent reports. Importantly, both ISS and Glass Lewis indicated that shareholders would not be best served by Mr. Barnhill and his nominees obtaining control of the Board.

Mr. Barnhill has not responded to the proposal or made any other effort to find a way to end the expensive and disruptive consent solicitation. We believe it is critical to deliver a lasting peace so that Mr. Mukerjee and the management team are afforded the time and room they deserve to focus on the strategic plan and turn TESSCO around. Mr. Barnhill’s refusal to respond or consider a settlement proposal that two independent advisory firms believe is ideal suggests Mr. Barnhill is not seeking what is best for TESSCO, but is instead focused on securing control of the TESSCO Board.

Shareholders should consider why Mr. Barnhill is so focused on obtaining a majority of the Board seats. Under our settlement proposal, Mr. Barnhill would need to convince just two directors (in addition to two of his nominees that would be elected to the Board under the proposal) that any future course of action is good for the Company. Why is Mr. Barnhill so fearful that he will not be able to do so?

Shareholders should be particularly concerned given that earlier this year Mr. Barnhill took steps to acquire the Company, and in so doing refused to abide by appropriate and conventional procedures to ensure such a transaction would be fair to all shareholders. Nothing prevents Mr. Barnhill from again seeking to acquire or take TESSCO private. In such case, the best way to assure the best price for all shareholders is to follow a fair process administered by a Board that is not controlled by Mr. Barnhill and his hand-picked nominees. If Mr. Barnhill wants to buy TESSCO, he should have to convince directors that are independent of his influence that such a transaction is in the interest of all shareholders.

If shareholders consent to Mr. Barnhill’s plan, Mr. Barnhill will re-establish a significant position of influence at TESSCO, which has not served TESSCO well over the past decade. With a hand-picked Board, Mr. Barnhill will likely have latitude to retain excessive influence on the Board, despite Mr. Barnhill’s lack of new ideas (as confirmed by both ISS and Glass Lewis) and an exceptional CEO that needs the flexibility to turn TESSCO around, including by reversing some of the value-destructive decisions made by Mr. Barnhill during his tenures as CEO and as Executive Chairman.

We urge shareholders to protect the future of their investment and prevent Mr. Barnhill and his nominees from gaining control of the TESSCO Board by signing, dating and returning the enclosed GREEN Consent Revocation Card TODAY.

TESSCO shareholders are reminded that their vote is important, no matter how many or how few shares they own. TESSCO urges you to support the TESSCO settlement proposal and your company’s Board by signing, dating and returning the enclosed GREEN Consent Revocation Card TODAY. If you receive a White Consent Card from Robert B. Barnhill, Jr., please disregard it.

If you have any questions or need assistance executing your revocation,

please contact TESSCO’s proxy solicitor,

Innisfree M&A Incorporated

Shareholders may call toll-free: (877) 800-5195

Banks and Brokers may call collect: (212) 750-5833

Sidley Austin LLP and Ballard Spahr LLP are serving as legal counsel to the Special Committee of TESSCO’s Board of Directors.

About TESSCO Technologies Incorporated (NASDAQ: TESS)

TESSCO Technologies, Inc. (NASDAQ: TESS) is a value-added technology distributor, manufacturer, and solutions provider serving commercial and retail customers in the wireless infrastructure and mobile device accessories markets. The company was founded more than 30 years ago with a commitment to deliver industry-leading products, knowledge, solutions, and customer service. TESSCO supplies more than 46,000 products from 350 of the industry’s top manufacturers in mobile communications, Wi-Fi, Internet of Things (“IoT”), wireless backhaul, and more. TESSCO is a single source for outstanding customer experience, expert knowledge, and complete end-to-end solutions for the wireless industry. For more information, visit www.tessco.com.

Forward-Looking Statements

This release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained herein, including statements regarding our future results of operations and financial position, strategy and plans and future prospects, and our expectations for future operations, are forward-looking statements. These forward-looking statements are based on current expectations and analysis, and actual results may differ materially from those projected. These forward-looking statements may generally be identified by the use of the words “may,” “will,” “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “seeks,” “believes,” “estimates,” and similar expressions, but the absence of these words or phrases does not necessarily mean that a statement is not forward-looking. These forward-looking statements are only predictions and involve a number of risks, uncertainties and assumptions, many of which are outside of our control. Our actual results may differ materially and adversely from those described in or contemplated by any such forward-looking statement for a variety of reasons, including those risks identified in our most recent Annual Report on Form 10-K and other periodic reports filed with the Securities and Exchange Commission (the “SEC”), under the heading “Risk Factors” and otherwise. Consequently, the reader is cautioned to consider all forward-looking statements in light of the risks to which they are subject. For additional information with respect to risks and other factors which could occur, see Tessco’s Annual Report on Form 10-K for the year ended March 29, 2020, including Part I, Item 1A, “Risk Factors” therein, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other securities filings with the SEC that are available at the SEC’s website at www.sec.gov and other securities regulators.

We are not able to identify or control all circumstances that could occur in the future that may materially and adversely affect our business and operating results. Without limiting the risks that we describe in our periodic reports and elsewhere, among the risks that could lead to a materially adverse impact on our business or operating results are the following: the impact and results of the consent solicitation and other activism activities by Robert B. Barnhill, Jr. and certain other participants in his consent solicitation and/or other activist investors, termination or non-renewal of limited duration agreements or arrangements with our vendors and affinity partners that are typically terminable by either party upon several months or otherwise relatively short notice; loss of significant customers or relationships, including affinity relationships; loss of customers either directly or indirectly as a result of consolidation among large wireless services carriers and others within the wireless communications industry; the strength of our customers’, vendors’ and affinity partners’ business; negative or adverse economic conditions, including those adversely affecting consumer confidence or consumer or business spending or otherwise adversely impacting our vendors or customers, including their access to capital or liquidity, or our customers’ demand for, or ability to fund or pay for, the purchase of our products and services; our dependence on a relatively small number of suppliers and vendors, which could hamper our ability to maintain appropriate inventory levels and meet customer demand; changes in customer and product mix that affect gross margin; effect of “conflict minerals” regulations on the supply and cost of certain of our products; failure of our information technology system or distribution system; system security or data protection breaches; technology changes in the wireless communications industry or technological failures, which could lead to significant inventory obsolescence and/or our inability to offer key products that our customers demand; third-party freight carrier interruption; increased competition from competitors, including manufacturers or national and regional distributors of the products we sell and the absence of significant barriers to entry which could result in pricing and other pressures on profitability and market share; our relative bargaining power and inability to negotiate favorable terms with our vendors and customers; our inability to access capital and obtain financing as and when needed; transitional and other risks associated with acquisitions of companies that we may undertake in an effort to expand our business; claims against us for breach of the intellectual property rights of third parties; product liability claims; our inability to protect certain intellectual property, including systems and technologies on which we rely; our inability to hire or retain for any reason our key professionals, management and staff; health epidemics or pandemics or other outbreaks or events, or national or world events or disasters beyond our control; and the possibility that, for unforeseen or other reasons, we may be delayed in entering into or performing, or may fail to enter into or perform, anticipated contracts or may otherwise be delayed in realizing or fail to realize anticipated revenues or anticipated savings.

The above list should not be construed as exhaustive and should be read in conjunction with our other disclosures, including but not limited to the risk factors described in our most recent Annual Report on Form 10-K and other periodic reports filed with the SEC, under the heading “Risk Factors” and otherwise. Other risks may be described from time to time in our filings made under the securities laws. New risks emerge from time to time. It is not possible for our management to predict all risks.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. In addition, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. We disclaim any duty to update any of these forward-looking statements after the date of this press release to confirm these statements to actual results or revised expectations.

Important Additional Information and Where to Find It

In connection with the consent solicitation initiated by Robert B. Barnhill, Jr. and certain other participants, TESSCO Technologies Incorporated (the “Company”) has filed a consent revocation statement and accompanying GREEN consent revocation card and other relevant documents with the Securities and Exchange Commission (the “SEC”). SHAREHOLDERS ARE STRONGLY ENCOURAGED TO CAREFULLY READ THE COMPANY’S CONSENT REVOCATION STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), ACCOMPANYING GREEN CONSENT REVOCATION CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Shareholders may obtain a free copy of the consent revocation statement, any amendments or supplements to the consent revocation statement and other documents that the Company files with the SEC at the SEC’s website at www.sec.gov or the Company’s website at https://ir.tessco.com as soon as reasonably practicable after such materials are electronically filed with, or furnished to, the SEC.

Cindy King, TESSCO

+1 410 229 1161 or [email protected]

Media

Jeff Kauth / Aiden Woglom

Joele Frank Wilkinson Brimmer Katcher

(212) 355-4449

Investors

Larry Miller / Gabrielle Wolf

Innisfree M&A Incorporated

Phone: (212) 750-5833

KEYWORDS: Maryland United States North America

INDUSTRY KEYWORDS: Technology Mobile/Wireless Internet Other Technology

MEDIA:

VICI Properties Announces Donation of Bluegrass Downs

VICI Properties Announces Donation of Bluegrass Downs

NEW YORK–(BUSINESS WIRE)–
VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”) announced that it has agreed to gift nearly 58 acres of land that formerly housed the Bluegrass Downs Race Track, located in Paducah, KY, to McCracken County. The land will be used as a youth recreational sports complex for soccer, baseball and softball to benefit roughly 1,200 children in the local area. Bluegrass Downs ceased operations in October 2019. This transaction does not impact any of the Company’s lease agreements.

John Payne, President and Chief Operating Officer of VICI Properties, said, “VICI is glad to be able to make this donation, which will directly benefit the communities in Paducah and McCracken County.”

Craig Clymer, McCracken County Judge-Executive, said, “We are delighted. The location is perfect for our needs. For decades, kids have been playing soccer at the old landfill site. This gives us the opportunity to dramatically improve our situation. We have heard from so many parents about traveling on weekends to play in other cities. Now we have a chance to attract others to McCracken County. I wish to thank VICI for its generous contribution.”

About VICI Properties

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties’ national, geographically diverse portfolio consists of 28 gaming facilities comprising 47 million square feet and features approximately 18,000 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars, Century Casinos, Hard Rock International, JACK Entertainment and Penn National Gaming. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties’ strategy is to create the nation’s highest quality and most productive experiential real estate portfolio. For additional information, please visit www.viciproperties.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. You can identify these statements by our use of the words “anticipates,” “assumes,” “believes,” “estimates,” “expects,” “guidance,” “intends,” “plans,” “projects,” and similar expressions that do not relate to historical matters. All statements other than statements of historical fact are forward-looking statements. You should exercise caution in interpreting and relying on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors which are, in some cases, beyond the Company’s control and could materially affect actual results, performance, or achievements. Among those risks, uncertainties and other factors are the impact of changes in general economic conditions, including low consumer confidence, unemployment levels and depressed real estate prices resulting from the severity and duration of any downturn in the U.S. or global economy (including stemming from the COVID-19 pandemic and changes in the economic conditions as a result of the COVID-19 pandemic).

Although the Company believes that in making such forward-looking statements its expectations are based upon reasonable assumptions, such statements may be influenced by factors that could cause actual outcomes and results to be materially different from those projected. The Company cannot assure you that the assumptions upon which these statements are based will prove to have been correct. Additional important factors that may affect the Company’s business, results of operations and financial position are described from time to time in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Reports on Form 10-Q and the Company’s other filings with the Securities and Exchange Commission. The Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.

Investor Contacts:

[email protected]

(646) 949-4631

Or

David Kieske

EVP, Chief Financial Officer

[email protected]


Danny Valoy

Vice President, Finance

[email protected]

Media Contacts:

[email protected]

(646) 949-4631

KEYWORDS: Nevada New York Kentucky United States North America

INDUSTRY KEYWORDS: Banking Entertainment Professional Services Other Construction & Property Residential Building & Real Estate Lodging Destinations Construction & Property Travel Urban Planning Finance Casino/Gaming

MEDIA:

J.B. Hunt Announces Acquisition of Mass Movement, Inc., Its Fourth to Expand Final Mile Services Since 2017

J.B. Hunt Announces Acquisition of Mass Movement, Inc., Its Fourth to Expand Final Mile Services Since 2017

LOWELL, Ark.–(BUSINESS WIRE)–
J.B. Hunt Transport Services, Inc. (NASDAQ: JBHT), one of the largest supply chain solutions providers in North America, announced today that its subsidiary, J.B. Hunt Transport, Inc., acquired the assets of Mass Movement, Inc. on November 30.

“Mass Movement presents an opportunity to expand our expertise in the final mile delivery of big and bulky products,” said John Roberts, president and CEO of J.B. Hunt. “The acquisition complements our current service and will enhance our ability to meet the growing demand of customers in the commercial health and fitness industry.”

Mass Movement has more than 20 years of experience providing logistics, delivery, assembly, and installation services for the commercial fitness industry and finished 2019 with $29 million of revenue. Founded by Dom Simonetti and Jim Sullivan in 1996, the company has delivered two million-plus pieces of equipment to more than 3,500 fitness centers throughout North America. Both founders will become employees of J.B. Hunt and will continue in leadership roles as the company expands its fitness equipment delivery business.

“Mass Movement is highly regarded among industry manufacturers and facility owners,” said Nick Hobbs, executive vice president and president of Dedicated Contract Services and Final Mile Services. “Its reputation and service quality align with ours, and we look forward to welcoming Mass Movement’s employees to the J.B. Hunt family.”

The acquisition is J.B. Hunt’s fourth since 2017 and will broaden the company’s industry-leading Final Mile Services, which operates one of the largest nationwide, commingled cross-dock operations. With 117 locations and over 3.4 million square feet of warehouse and facilities space, Final Mile has the ability to serve 100% of the contiguous United States. In 2019, J.B. Hunt acquired the assets of RDI Last Mile Co. and Cory 1st Choice Home Delivery. The company also purchased Special Logistics Dedicated in 2017.

The transaction was funded using cash on hand, and the law firm of Mitchell, Williams, Selig, Gates & Woodyard, PLLC served as legal advisor to J.B. Hunt.

About J.B. Hunt

J.B. Hunt Transport Services, Inc., an S&P 500 company, provides innovative supply chain solutions for a variety of customers throughout North America. Utilizing an integrated, multimodal approach, the company applies technology-driven methods to create the best solution for each customer, adding efficiency, flexibility, and value to their operations. J.B. Hunt services include intermodal, dedicated, refrigerated, truckload, less-than-truckload, flatbed, single source, final mile, and more. J.B. Hunt Transport Services, Inc. stock trades on NASDAQ under the ticker symbol JBHT and is a component of the Dow Jones Transportation Average. J.B. Hunt Transport, Inc. is a wholly owned subsidiary of JBHT. For more information, visitwww.jbhunt.com.

Brad Delco

Vice President – Finance and Investor Relations

(479) 820-2723

KEYWORDS: Arkansas United States North America

INDUSTRY KEYWORDS: Trucking Transport Logistics/Supply Chain Management

MEDIA:

Logo
Logo